Skip to Content
Merck
  • SNT-2 interacts with ERK2 and negatively regulates ERK2 signaling in response to EGF stimulation.

SNT-2 interacts with ERK2 and negatively regulates ERK2 signaling in response to EGF stimulation.

Biochemical and biophysical research communications (2004-10-16)
Lin Huang, Noriko Gotoh, Shengliang Zhang, Masabumi Shibuya, Tadashi Yamamoto, Nobuo Tsuchida
ABSTRACT

The control of cellular responses with fibroblast growth factors and neurotrophins is mediated through membrane-linked docking proteins, SNT (suc1-binding neurotrophic target)-1/FRS2alpha and SNT-2/FRS2beta. ERK1/2 are members of the mitogen-activated protein kinase family that regulate diverse cellular activities in response to various stimuli. Here, we demonstrate that SNT-2 does not become tyrosine phosphorylated significantly in response to EGF but forms a complex with ERK2 via the region of 186-252 amino acid residues, and the complex formation is enhanced upon EGF stimulation. SNT-2 downregulates ERK2 phosphorylation, suppresses and delays ERK2 nuclear accumulation which occurs following EGF stimulation. In contrast, the mutant SNT-2 which carries deletion of 186-252 amino acids and lacks ERK2 binding does not have these effects. These observations suggest that SNT-2 negatively regulates ERK2 signaling activated via EGF stimulation through direct binding to ERK2.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
FRS3, GST tagged human, recombinant, expressed in baculovirus infected Sf9 cells, ≥70% (SDS-PAGE), buffered aqueous glycerol solution